Cruz RA, Chaudhary S, Guevara M, Meltzer E. Neuromyelitis optica spectrum disorders (NMOSD) and connective tissue disease (CTD): an update for the rheumatologist. Curr Rheumatol Rep. 2021;23(6):33.

Article  PubMed  Google Scholar 

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.

Article  PubMed  PubMed Central  Google Scholar 

Wingerchuk DM, Lucchinetti CF. Neuromyelitis optica spectrum disorder. N Engl J Med. 2022;387(7):631–9.

Article  PubMed  Google Scholar 

Jarius S, Wildemann B. The history of neuromyelitis optica. J Neuroinflammation. 2013;10:8.

Article  PubMed  PubMed Central  Google Scholar 

Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364(9451):2106–12.

Article  CAS  PubMed  Google Scholar 

• Pruss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021;21(12):798–813. Article describing the inherent pathological mechanisms underlying NMO.

Banwell B, Bennett JL, Marignier R, Kim HJ, Brilot F, Flanagan EP, et al. Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria. Lancet Neurol. 2023;22(3):268–82.

Article  CAS  PubMed  Google Scholar 

Kim SM, Kim SJ, Lee HJ, Kuroda H, Palace J, Fujihara K. Differential diagnosis of neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord. 2017;10(7):265–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shahmohammadi S, Doosti R, Shahmohammadi A, Mohammadianinejad SE, Sahraian MA, Azimi AR, et al. Autoimmune diseases associated with Neuromyelitis Optica Spectrum Disorders: a literature review. Mult Scler Relat Disord. 2019;27:350–63.

Article  PubMed  Google Scholar 

Hor JY, Asgari N, Nakashima I, Broadley SA, Leite MI, Kissani N, et al. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide. Front Neurol. 2020;11:501.

Article  PubMed  PubMed Central  Google Scholar 

Papp V, Magyari M, Aktas O, Berger T, Broadley SA, Cabre P, et al. Worldwide incidence and prevalence of neuromyelitis optica: a systematic review. Neurology. 2021;96(2):59–77.

PubMed  PubMed Central  Google Scholar 

Hyun JW, Woodhall MR, Kim SH, Jeong IH, Kong B, Kim G, et al. Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases. J Neurol Neurosurg Psychiatry. 2017;88(10):811–7.

Article  PubMed  Google Scholar 

Kim KH, Kim SH, Hyun JW, Kim Y, Park H, Kim HJ. Seroprevalence of anti-myelin oligodendrocyte glycoprotein antibodies in adults with myelitis. Ann Clin Transl Neurol. 2022;9(9):1481–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Molazadeh N, Bose G, Lotan I, Levy M. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a systematic review. Mult Scler J Exp Transl Clin. 2022;8(4):20552173221128170.

PubMed  PubMed Central  Google Scholar 

Eskandarieh S, Nedjat S, Abdollahpour I, Azimi AR, Moghadasi AN, Asgari N, et al. Environmental risk factors in neuromyelitis optica spectrum disorder: a case-control study. Acta Neurol Belg. 2018;118(2):277–87.

Article  PubMed  Google Scholar 

Stiebel-Kalish H, Rubarth K, Shouchane-Blum K, Tiosano A, Lotan I, Hellmann MA, et al. Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis. Sci Rep. 2022;12(1):21312.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen X, Fan R, Peng F, Liu J, Huang J, Chen Z, et al. Blood pressure and body fat percent in women with NMOSD. Brain Behav. 2019;9(9): e01350.

Article  PubMed  PubMed Central  Google Scholar 

Cho EB, Yeo Y, Jung JH, Jeong SM, Han K, Yang JH, et al. Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide cohort study in South Korea. Mult Scler. 2022;28(12):1849–58.

Article  CAS  PubMed  Google Scholar 

Alvarenga MP, do Carmo LF, Vasconcelos CCF, Alvarenga MP, Alvarenga-Filho H, de Melo Bento CA, et al. Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis. Sci Rep. 2021;11(1):152.

Matsushita T, Masaki K, Isobe N, Sato S, Yamamoto K, Nakamura Y, et al. Genetic factors for susceptibility to and manifestations of neuromyelitis optica. Ann Clin Transl Neurol. 2020;7(11):2082–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morris DL, Taylor KE, Fernando MM, Nititham J, Alarcon-Riquelme ME, Barcellos LF, et al. Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans. Am J Hum Genet. 2012;91(5):778–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

•• Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473–7. Role of aquaporin-4 in multiple sclerosis.

Pan QL, Lin FX, Liu N, Chen RC. The role of aquaporin 4 (AQP4) in spinal cord injury. Biomed Pharmacother. 2022;145: 112384.

Article  CAS  PubMed  Google Scholar 

Chang VTW, Chang HM. Review: Recent advances in the understanding of the pathophysiology of neuromyelitis optica spectrum disorder. Neuropathol Appl Neurobiol. 2020;46(3):199–218.

Article  CAS  PubMed  Google Scholar 

Sabatino JJ Jr, Probstel AK, Zamvil SS. B cells in autoimmune and neurodegenerative central nervous system diseases. Nat Rev Neurosci. 2019;20(12):728–45.

Article  CAS  PubMed  Google Scholar 

Maciak K, Pietrasik S, Dziedzic A, Redlicka J, Saluk-Bijak J, Bijak M, et al. Th17-related cytokines as potential discriminatory markers between neuromyelitis optica (Devic’s disease) and Multiple Sclerosis-A Review. Int J Mol Sci. 2021;22(16).

Jarius S, Paul F, Weinshenker BG, Levy M, Kim HJ, Wildemann B. Neuromyelitis optica Nat Rev Dis Primers. 2020;6(1):85.

Article  PubMed  Google Scholar 

Saadoun S, Papadopoulos MC. Role of membrane complement regulators in neuromyelitis optica. Mult Scler. 2015;21(13):1644–54.

Article  CAS  PubMed  Google Scholar 

Vourc’h P, Andres C. Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function. Brain Res Brain Res Rev. 2004;45(2):115–24.

Article  CAS  PubMed  Google Scholar 

Ambrosius W, Michalak S, Kozubski W, Kalinowska A. Myelin Oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management. Int J Mol Sci. 2020;22(1).

Takai Y, Misu T, Kaneko K, Chihara N, Narikawa K, Tsuchida S, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study. Brain. 2020;143(5):1431–46.

Article  PubMed  Google Scholar 

Devic E. Myélite aiguë dorso-lombaire avec névrite optique.-Autopsie. Congrès français de médecine. 1895;434–9.

Abel A, McClelland C, Lee MS. Critical review: typical and atypical optic neuritis. Surv Ophthalmol. 2019;64(6):770–9.

Article  PubMed  Google Scholar 

Lucas S, Lalive PH, Lascano AM. Paroxysmal painful tonic spasms in neuromyelitis optica spectrum disorder. eNeurologicalSci. 2023;30:100443.

Netravathi M, Saini J, Mahadevan A, Hari-Krishna B, Yadav R, Pal PK, et al. Is pruritus an indicator of aquaporin-positive neuromyelitis optica? Mult Scler. 2017;23(6):810–7.

Article  PubMed  Google Scholar 

Camara-Lemarroy CR, Burton JM. Area postrema syndrome: a short history of a pearl in demyelinating diseases. Mult Scler. 2019;25(3):325–9.

Article  PubMed  Google Scholar 

Kremer L, Mealy M, Jacob A, Nakashima I, Cabre P, Bigi S, et al. Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients. Mult Scler. 2014;20(7):843–7.

Article  CAS  PubMed  Google Scholar 

Beigneux Y, Arnulf I, Guillaume-Jugnot P, Leu-Semenescu S, Maillart E, Lubetzki C, et al. Secondary hypersomnia as an initial manifestation of neuromyelitis optica spectrum disorders. Mult Scler Relat Disord. 2020;38: 101869.

Article  PubMed  Google Scholar 

Etemadifar M, Nouri H, Khorvash R, Salari M, Ghafari K, Aghababaee A. Frequency of diencephalic syndrome in NMOSD. Acta Neurol Belg. 2022;122(4):961–7.

Article  PubMed  Google Scholar 

Pandit L, Asgari N, Apiwattanakul M, Palace J, Paul F, Leite MI, et al. Demographic and clinical features of neuromyelitis optica: a review. Mult Scler. 2015;21(7):845–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim SH, Mealy MA, Levy M, Schmidt F, Ruprecht K, Paul F, et al. Racial differences in neuromyelitis optica spectrum disorder. Neurology. 2018;91(22):e2089–99.

Article  PubMed  PubMed Central  Google Scholar 

Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ. Clinical utility of testing AQP4-IgG in CSF: guidance for physicians. Neurol Neuroimmunol Neuroinflamm. 2016;3(3): e231.

Article  PubMed  PubMed Central  Google Scholar 

Masha N, Kimbrough DJ, Eckstein CP, Hudak NM, Skeen MB, Hartsell FL, et al. Neuromyelitis optica: clinical course and potential prognostic indicators. Mult Scler Relat Disord. 2023;69: 104414.

Article  CAS